Audited Financial Results (both Standalone and Consolidated) for the quarter and financial year ended 31st March 2026 and Outcome of Board Meeting
DCMSHRIRAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
DCM Shriram Ltd reported strong full-year results for FY2026. Standalone total income grew 11% to Rs 13,995 crore from Rs 12,584 crore in FY2025. Profit after tax surged 48% to Rs 837.55 crore from Rs 566.53 crore, driven by higher revenues and operating efficiency. EBITDA improved to Rs 1,639.53 crore (vs Rs 1,409.85 crore). EPS rose to Rs 53.71 per share from Rs 36.33. The company declared a total dividend of Rs 11.20 per share (560%) for the year, including Rs 4 final dividend. Key board decisions include a Rs 100 crore financial assistance to subsidiary HSCL for capacity expansion, cancellation of 39 lakh forfeited shares, and AGM scheduled for August 2026. Auditors Deloitte gave an unmodified opinion with no qualifications.
Strong 48% PAT growth and robust cash generation indicate healthy operational performance. The expansion plans in specialty chemicals and Epichlorohydrin capacity commissioned in April 2026 position the company well for future growth. Positive shareholder returns through dividend.